[ Price : $8.95]
An OFW Law client tells FDA it supports a petition asking the agency to rule that Ranbaxy has lost its 180-day exclusivity for sev...[ Price : $8.95]
FDA asks members of its Oncologic Drugs Advisory Committee to weigh the benefits of Novartis Farydak in patients with relapsed mul...[ Price : $8.95]
Hospira begins a Class 1 recall of its GemStar Power Supply, 3VDC, due to performance issues.[ Price : $8.95]
The Centers for Medicare & Medicaid Services revises its reporting requirements under the Physician Payments Sunshine Act to exclu...[ Price : $8.95]
A Tufts Center for the Study of Drug Development analysis finds that central nervous system drugs take longer to develop and appro...[ Price : $8.95]
FDAs Kansas City District Office warns BioMerieux about Quality System violations at its Hazelwood, MO, facility.[ Price : $8.95]
FDA clears a Covidien 510(k) for the HawkOne directional atherectomy system.[ Price : $8.95]
The FDA Denver District Office warns Xanacare about Quality System and other violations in its manufacturing of the SimulCare II t...